Search

everythinglearnresearchcommunity

for

Search:↓

Atopic dermatitis affects the appearance of skin reactions, making certain features more common and improving diagnostic accuracy with dermoscopy.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

EPDS is a rare, chronic scalp condition that's hard to treat and needs better awareness for improved outcomes.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

The research found that Atypical Progeroid Syndrome has unique symptoms and is not caused by the buildup of a certain mutant protein.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

Hair dye ingredient PPD can cause severe allergic reactions, including facial swelling.

Early diagnosis and genetic counseling are crucial for managing adrenoleukodystrophy.

Early treatment of EPDS can improve outcomes and reduce recurrence risk.

Autoimmune polyglandular syndrome can cause temporary brain issues that may improve on their own.

DDS treatment for LABD can cause severe side effects like anemia and hair loss, requiring careful monitoring.

Apremilast may help treat hair loss in alopecia areata.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

The AAPPO questionnaire is a reliable tool for assessing hair loss impact in alopecia areata patients.

FAPD in children may not depend on androgens and should be treated with anti-inflammatory measures and minoxidil.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Precocious puberty can signal familial adenomatous polyposis.

Two patients with stubborn hair loss grew hair after PDRN injections.

The supplement aims to improve care for children with alopecia areata.

Early recognition and multidisciplinary management of Whitaker syndrome can improve patient outcomes.

Diphenylcyclopropenone is effective and safe for treating severe alopecia areata in children, with maintenance therapy reducing relapse risk.

Patients with one autoimmune disease should be checked for other autoimmune disorders.

Organizations help patients access discounts for expensive dermatology medications.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.